Clik here to view.
Clik here to view.
Teikoku Pharma USA and Link Health Enter into License Agreement for Lidoderm®...
SAN JOSE, Calif. Teikoku Pharma USA Inc. (“TPU”) today announced that it has entered into an exclusive license agreement with Link Health Group LTD (“Link Health”) to develop market, sell, and...
View ArticleClik here to view.
vTv Therapeutics Announces Licensing Agreement with Newsoara Biopharma Co....
HIGH POINT, N.C. vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that vTv Therapeutics LLC has entered into an exclusive licensing agreement with Newsoara Biopharma Co., Ltd. for rights to...
View ArticleClik here to view.
FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboration
WATERTOWN, Mass. & CHENGDU, China FORMA Therapeutics and HitGen Ltd. today announced a multiyear research collaboration and license agreement to build and screen proprietary DNA-encoded...
View ArticleClik here to view.
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement...
SHANGHAI & ROTTERDAM, Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has licensed its patented H2L2 fully human antibody discovery platform to Celsius Therapeutics, a...
View ArticleClik here to view.
Samsung Bioepis Announces Results of Additional One-Year Follow-up Study on...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced additional one-year follow-up study results on SB3, a biosimilar candidate referencing Herceptin® 1 (trastuzumab). The data was made...
View ArticleClik here to view.
Seattle Genetics and Astellas Present at ASCO 2018 on Enfortumab Vedotin in...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced the presentation of...
View ArticleClik here to view.
タイヨウ・パシフィック・パートナーズ、そーせいグループ（4565）株式を 5％超取得
東京 （ビジネスワイヤ）– タイヨウ･パシフィック・パートナーズは本日、そーせいグループ株式会社（4565）の発行済株式総数の 5％超を取得し、実質調査ベースで第...
View ArticleClik here to view.
Taiyo Pacific Partners Becomes Major Shareholder in Sosei Group Corporation...
TOKYO Taiyo Pacific Partners announced today that it has accumulated in excess of 5% in Sosei Group Corporation (4565) to become Sosei’s second largest shareholder. The company (or “Sosei”) is an...
View ArticleClik here to view.
Nerviano Medical Sciences宣布与默克签署合作及授权协议，以发现某些抗癌靶点的小分子抑制剂
意大利内尔维亚诺 (美国商业资讯) — 意大利最大的制药研发机构、欧洲领先的专攻肿瘤领域的发现及开发一体化公司之一Nerviano Medical Sciences今天宣布，与领先的科技公司默克签署协议，合作发现面向抗癌药开发的小分子抑制剂。 根据协议条款，Nerviano Medical...
View ArticleClik here to view.
Clik here to view.
Pierre Fabre and Its Partner Array BioPharma Announce Additional Median...
CASTRES, France Pierre Fabre and its partner Array BioPharma Inc. today announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma. The results showed median overall...
View ArticleClik here to view.
DiaCarta Named to CIO Applications’ “Top 25 Life Sciences Technology Vendors...
FREMONT, Calif. CIO Applications has chosen DiaCarta as one of the Top 25 Life Sciences Technology Vendors 2018. The positioning is based on an evaluation of DiaCarta’s specialty in personalized...
View ArticleClik here to view.
和铂医药携手美国Wistar研究所，共同推进针对肿瘤和感染性疾病的抗体新药研发
美国费城、剑桥，荷兰鹿特丹，中国上海 (美国商业资讯)–和铂医药和Wistar研究所今天宣布，双方将开展一项长期、多方面的研究合作，共同研发治疗肿瘤和感染性疾病的系列创新型抗体药物。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20180604005745/zh-CN/...
View ArticleClik here to view.
Harbour BioMed and The Wistar Institute Join Forces to Advance Novel Antibody...
CAMBRIDGE, Mass. & PHILADELPHIA & SHANGHAI Harbour BioMed and The Wistar Institute announced today that they have entered into a multi-year, multifaceted research collaboration to...
View ArticleClik here to view.
Verastem Oncology and Yakult Honsha Co., Ltd. Sign Exclusive License...
BOSTON & TOKYO Verastem, Inc. (President and CEO: Robert Forrester)(NASDAQ:VSTM) and Yakult Honsha Co., Ltd. (President: Takashige Negishi)(Tokyo:2267), today announced their entry into an...
View ArticleClik here to view.
Fujifilm Completes Acquisition of Irvine Scientific Sales Company and IS...
SANTA ANA, Calif. FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD. (ISJ),...
View ArticleClik here to view.
IONTAS Signs Collaboration Agreement With LG Chem, Ltd. to Identify...
CAMBRIDGE, England & SEOUL, South Korea IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement...
View ArticleClik here to view.
AtriCure and Baheal Group Establish Partnership and China Distribution Agreement
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has partnered with...
View ArticleClik here to view.
Shionogi Announces Upcoming Presentations at American Society for...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) announced today that eight scientific posters will feature the company’s investigational compounds at the...
View Article